'김갑성' 기자의 전체기사
-
Leaders Dental Accelerates Global Expansion With AI-CAD an…
SEOUL, South Korea, Dec. 2, 2025 -- Leaders Dental Laboratory (branded globally as LEADERS DENTAL), a leading digital dental laboratory in Korea, is rapidly strengthening its presence in the global digital dentistry market with its flagship product, the surgical guide. Backed by recent export achievements in five countries—including the United Kingdom, Japan, and Taiwan—the company is expanding exports of its integrated digital solution packages to align with the global shift from single implant components to fully systemized workflows. LEADERS DENTAL operates a large-scale digital man
- 김갑성 기자
- 2025-12-02 08:00
-
Suchang Accelerates Global Expansion With Dog Food Mad…
SEOUL, South Korea, Dec. 2, 2025 -- Suchang a Korean manufacturer specializing in over 150 types of natural bio-based ingredients and overseas distribution consulting, announced that it has successfully developed a new dog food product using gamgyul-bak—by-products from Jeju's citrus processing industry. Tentatively branded as "Orange Dogs," the new product is designed for global markets, with export plans targeting the United States, Japan, China, and Europe. Originally operating as a B2B-focused bio-raw material manufacturer, Suchang has launched the "Orange Dogs"
- 김갑성 기자
- 2025-12-02 08:00
-
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allo…
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced that its innovative TYK2 allosteric inhibitor, LNK01006, has been approved by U.S. Food and Drug Administration (FDA) for human clinical trials. LNK01006 is a highly brain-penetrant, potent, and selective oral TYK2 allosteric inhibitor targeting the JH2 domain. TYK2 is a key regulator of th
- 김갑성 기자
- 2025-12-02 08:00
-
Ziwig Endotest®: Scientific Validation Published in NEJM Evide…
LYON, France, Dec. 2, 2025 -- NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based diagnostic test developed by Ziwig. The publication reports the results of a prospective, independent, multicenter clinical study conducted in France. The study enrolled 971 symptomatic women aged 18 to 43 years across 17 public and private hospitals. High-performance saliva-based diagnosis The Ziwig Endotest® was evaluated thro
- 김갑성 기자
- 2025-12-02 06:00
-
Building Families with Innovation: Patient-First Vision Goes Dig…
SYDNEY, Dec. 2, 2025 -- Miroma Project Factory (MPF) was delighted to welcome Westmead Fertility Centre to the agency fold for a wide-reaching digital transformation initiative. The engagement began with a comprehensive audit of Westmead Fertility Centre's digital infrastructure to identify opportunities across systems, tools, and platforms to deliver a truly patient-focused experience. This discovery phase included detailed user and stakeholder research, which has informed a robust patient-led digital transformation. Spearheaded by MPF's CEO and Technical Strategist, Kat Robinson and her tea
- 김갑성 기자
- 2025-12-02 05:07
-
OSR Holdings to Present at the Emerging Growth Conference o…
BELLEVUE, Wash., Dec. 2, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. This presentation will provide investors and analysts with an updated overview of OSR Holdings' diversified healthcare platforms and strategic growth initiatives. Virtual Presentation Details Date: December 10, 2025 Time: 9:05 a.m. ET Format: Corporate Overview Registration Link: https://goto.
- 김갑성 기자
- 2025-12-02 04:01
-
CQ Medical® Expands Radiation Therapy Portfolio With Bionix…
AVONDALE, Pa., Dec. 2, 2025 -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its patient positioning and marking product portfolio. The acquisition reinforces CQ Medical's mission to advance precision in radiotherapy, empowering clinicians and improving outcomes worldwide. Bionix has established a strong reputation of developing innovative, high-quality medical devices across multiple patient care segments for over 40 years. Following
- 김갑성 기자
- 2025-12-02 02:07
-
United Imaging Broadens Imaging Portfolio and Advances N…
[ 메디채널 김갑성 기자 ] The company brings a full array of technology to its two booths in Chicago, showcasing another year of increasing R&D and investment. CHICAGO, Dec. 2, 2025 -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2025. Under the theme "Passion for Change, For One and All," the company will highlight how its technology is built to see the uniqueness of each individual and extend access to advanced care across different communities. The portfolio on d
- 김갑성 기자
- 2025-12-02 00:00
-
American Power Systems unveils high-output dual alternator…
Get more onboard power with minimal changes to OE under-the-hood configuration DAVENPORT, Iowa, Dec. 1, 2025 -- When it comes to outfitting vehicles for security, defense, or demanding commercial applications, the Nissan Patrol stands out as a reliable platform. But as these vehicles are upgraded with additional armor and specialized equipment, their electrical power needs often exceed what standard OEM alternators can provide. That's where the new dual alternator bracket kit for the Nissan Patrol from US-based American Power Systems, Inc. (APS) comes in: it's a game-changing s
- 김갑성 기자
- 2025-12-01 23:30
-
American Power Systems、Nissan Patrol向け高出力デュアル・オルタネ…
純正エンジン・ルーム構成への最小限の変更で車載電力を増強 アイオワ州ダベンポート, 2025年12月2日 -- セキュリティ、防衛、または過酷な商業用途向けの車両装備において、Nissan Patrolは信頼性の高いプラットフォームとして際立っています。しかし、これらの車両に追加装甲や特殊装備が搭載されるにつれ、その電力需要は標準OEMオルタネーターの供給能力を超えることが多くなります。そこで、米国American Power Systems, Inc.（APS）製のNissan Patrol向け新型デュアル・オルタネーター・ブラケット・キットが登場します。これは、現場で信頼性の高い高出力電源を必要とするオペレーターにとって、画期的なソリューションです。 新型デュアル・オルタネーター・ブラケット・キットにより、ユーザーは2017～24年式Nissan Patrol Y62（5.6L V8ガソリン・エンジン搭載車）に対し、純正ボンネット下構成への最小限の変更で追加出力を実現できます。具体的には、エンド・ユーザーはAPSの12V、24V、または48V高出力オルタネーターを追加し、12-12、12-24、または12-48のセカンダリー・オルタネーター電源システム構成を実現できます。 フィールドで安全とコネクティッドに過ごすための
- 김갑성 기자
- 2025-12-01 23:30
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-10_WED
- 이제 유니온페이 카드로 15개 국가에서 애플 서비스 온라인 결제 가능 18:46
- World Gym Corporation (2762.TW) Reports Robust November Revenue Growth and Unveils Ambitious 2026 Strategic Roadmap 18:30
- Admission To Trading on The London Stock Exchange and Completion of Secondary Listing 18:27
- Under the Patronage of His Royal Highness the Crown Prince Governor of Riyadh Region Inaugurates MOMENTUM 2025 Development Finance Conference 17:57
- 엘프바•로스트마리, 2025년 획기적인 R&D 성과 및 새로운 안전 프로토콜 공개 17:22
- Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment 17:15
- Berlin Heals Welcomes Rob ten Hoedt as New Chairman of the Board 17:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 10일 20시 10분